Table 1 ECT and MST dataset details for patients included in analysis.

From: Magnetic seizure therapy and electroconvulsive therapy increase aperiodic activity

 

ECT

MST

N

22

22

Age (median (IQR))

46.5 (32, 61)

47.5 (40.75, 52)

Gender (Male/Female)

8/12 (2 unknown)

11/11

HAM-D pre (median (IQR))

23 (22, 24) (HAMD-17)

26.5 (24, 29) (HAMD-24)

HAM-D post (median (IQR))

10 (8.5, 19) (HAMD-17)

20 (19, 26) (HAMD-24)

Number of treatments received (median (IQR))

14 (10, 17.5)

24 (18, 24)

Remission rate

63%

21%

Medications

Antidepressant

89%

65%

Antipsychotic

42%

25%

Anxiolytics

32%

15%

Stimulants

11%

15%

Sedative

68%

35%

  1. ECT dataset details were from Voineskos et al., 2016 [35] and further correspondence. MST dataset details were from Daskalakis et al., 2020 [36] and further correspondence. Remission rate was calculated as a percentage of the included patients in our analysis from the cohort that showed equal or larger than 50% decrease in symptom severity.
Back to article page